MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ejogrb.2011.05.023

Медицинская библиотека · European journal of obstetrics, gynecology, and reproductive biology · 2011

Value of HPV-DNA test in women with cytological diagnosis of atypical glandular cells (AGC).

Zeferino Luiz Carlos, Rabelo-Santos Silvia Helena, Villa Luísa Lina, Sarian Luis Otávio, Costa Maria Cecília, do Amaral Westin Maria Cristina, de Ângelo-Andrade Liliana Aparecida Lucci, Derchain Sophie

СтатьяПеревод в очереди

Аннотация

OBJECTIVE

This study analyzed whether HPV (human papillomavirus) testing contributes towards defining histological abnormalities in women with atypical glandular cells (AGC) diagnosed at cervical cytology.

STUDY

DESIGN

One hundred and eight women with conventional cervical cancer screening smears suggestive of AGC not otherwise specified (AGC-NOS) and favor neoplastic (AGC-FN) were consecutively enrolled. All women underwent colposcopic examinations and biopsy was performed according to the cytopathologic and/or colposcopic abnormalities present. All specimens were tested for high risk HPV genotypes by Roche's polymerase chain reaction reverse line blot assay. The chi-square test was used to evaluate the association between HPV findings and a diagnosis of high-grade pre-invasive or invasive disease (CIN 2 or worse) taking negative tests or CIN 1 as a reference. Odds ratios (OR) with their respective 95% confidence intervals (95%CI) were used to evaluate the magnitude of the association between HPV testing and CIN 2 or worse. Sensitivity, specificity and their respective 95% confidence intervals (95%CI), positive predictive values (PPV) and negative predictive values (NPV) were also calculated.

RESULTS

Final diagnosis revealed a negative outcome in 80 cases (74%), cervical epithelial neoplasia 1 (CIN 1) in 13 cases (12%), CIN 2 or worse in 12 cases (11%) and glandular neoplasia in 3 (3%) cases. The overall detection rate of HPV was 21% (23/108). Neoplasia was significantly associated with positive HPV-DNA in women with AGC-NOS (OR=15.21; 95%CI: 2.64-87.50); however, there was no significant association between a histological diagnosis of neoplasia and HPV positivity in women with AGC-FN (OR=3.00; 95%CI: 0.36-24.92). The sensitivity, specificity, positive predictive value and negative predictive value of HPV-DNA testing for the detection of CIN 2 or worse in women with AGC-NOS were 71%, 86%, 29% and 97%, respectively. In women with AGC-FN, these values were 50%, 75%, 66% and 60%, respectively.

CONCLUSIONS

HPV testing at the time of colposcopy for patients with AGC in whom no colposcopic abnormality is found may be a powerful ancillary tool for identifying women at a high risk of underlying significant cervical lesions.

Для цитирования: Zeferino Luiz Carlos, Rabelo-Santos Silvia Helena, Villa Luísa Lina, Sarian Luis Otávio, Costa Maria Cecília, do Amaral Westin Maria Cristina, de Ângelo-Andrade Liliana Aparecida Lucci, Derchain Sophie. Value of HPV-DNA test in women with cytological diagnosis of atypical glandular cells (AGC).. European journal of obstetrics, gynecology, and reproductive biology. 2011. DOI: 10.1016/j.ejogrb.2011.05.023.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.